260 related articles for article (PubMed ID: 3859319)
1. Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis.
Tricot G; Vlietinck R; Boogaerts MA; Hendrickx B; De Wolf-Peeters C; Van den Berghe H; Verwilghen RL
Br J Haematol; 1985 May; 60(1):19-32. PubMed ID: 3859319
[TBL] [Abstract][Full Text] [Related]
2. The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations.
Tricot G; Boogaerts MA; De Wolf-Peeters C; Van den Berghe H; Verwilghen RL
Br J Haematol; 1985 Apr; 59(4):659-70. PubMed ID: 3857071
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS.
Tricot G; De Wolf-Peeters C; Vlietinck R; Verwilghen RL
Br J Haematol; 1984 Oct; 58(2):217-25. PubMed ID: 6477833
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients.
van der Weide M; Sizoo W; Nauta JJ; Krefft J; Langenhuijsen MM
Eur J Haematol; 1988 Aug; 41(2):115-22. PubMed ID: 3165865
[TBL] [Abstract][Full Text] [Related]
5. Update on the prognostic implication of morphology, histology, and karyotype in primary myelodysplastic syndromes.
Verhoef G; De Wolf-Peeters C; Kerim S; Van De Broeck J; Mecucci C; Van den Berghe H; Boogaerts M
Hematol Pathol; 1991; 5(4):163-75. PubMed ID: 1794966
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.
Jacobs RH; Cornbleet MA; Vardiman JW; Larson RA; Le Beau MM; Rowley JD
Blood; 1986 Jun; 67(6):1765-72. PubMed ID: 3708160
[TBL] [Abstract][Full Text] [Related]
7. Clinical, hematological and histomorphological profile of myelodysplastic syndrome.
Nigam S; Rani S; Singh T; Gupta S; Rakheja D; Gaiha M
J Assoc Physicians India; 2001 Apr; 49():430-4. PubMed ID: 11762613
[TBL] [Abstract][Full Text] [Related]
8. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
Mangi MH; Mufti GJ
Blood; 1992 Jan; 79(1):198-205. PubMed ID: 1370203
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].
Rubio-Félix D; Giraldo MP; Perella M; Gimeno J; Franco E; Giralt M
Sangre (Barc); 1991 Dec; 36(6):463-9. PubMed ID: 1812580
[TBL] [Abstract][Full Text] [Related]
11. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
Ghaddar HM; Stass SA; Pierce S; Estey EH
Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in myelodysplastic syndromes: analysis of five scoring systems.
Rubio-Felix D; Giraldo P; Franco E; Gimeno J; Giralt M
Hematol Oncol; 1995; 13(3):139-52. PubMed ID: 7622144
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndromes: analysis of 131 cases according to the FAB classification.
Economopoulos T; Stathakis N; Foudoulakis A; Papadoulis N; Dervenoulas J; Papageorgiou E; Anastassiou C; Hadjioannou J; Raptis S
Eur J Haematol; 1987 Apr; 38(4):338-44. PubMed ID: 3609254
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy.
Fenaux P; Morel P; Rose C; Lai JL; Jouet JP; Bauters F
Br J Haematol; 1991 Apr; 77(4):497-501. PubMed ID: 2025575
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
[TBL] [Abstract][Full Text] [Related]
17. Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases.
Polychronopoulou S; Panagiotou JP; Kossiva L; Mavrou A; Anagnostou D; Haidas S
Acta Paediatr; 2004 Aug; 93(8):1015-23. PubMed ID: 15456186
[TBL] [Abstract][Full Text] [Related]
18. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases.
Kerkhofs H; Hermans J; Haak HL; Leeksma CH
Br J Haematol; 1987 Jan; 65(1):73-81. PubMed ID: 3814528
[TBL] [Abstract][Full Text] [Related]
19. Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia.
Weisdorf DJ; Oken MM; Johnson GJ; Rydell RE
Br J Haematol; 1983 Dec; 55(4):691-700. PubMed ID: 6608368
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors in myelodysplastic syndromes: analysis of 72 cases].
Krieger O; Bernhart M; Desser H; Nowotny H; Lutz D
Wien Klin Wochenschr; 1985 Feb; 97(3):131-6. PubMed ID: 3984346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]